Ochre Bio Ltd.

https://www.ochre-bio.com

LinkedIn: https://www.linkedin.com/company/ochre-bio

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases, a top ten global killer. We uncover new biological pathways by using advances in 'deep phenotyping', and then study our medicines in human livers kept alive on machines. In doing so, Ochre Bio ensures that the medicines we bring to the clinic are highly likely to successfully improve patient lives. Situated within the heart of Oxford’s biotech innovation hub, Ochre is built on over 15 years experience in liver genomics and bringing advanced therapies to market. *

	Start	2019-11-04 established
	Industry	BIOTECH
	Person	O’Meara, Jack (Ochre Bio 202106 CEO + Co-Founder)

	Region	Headington, Oxfordshire
	Country	United Kingdom (GB)
	Street	Roosevelt Drive BioEscalator, Innovation Building
	City	OX3 7FZ Headington, Oxford
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Ochre Bio Ltd.. (6/16/21). "Press Release: Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures". Oxford.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Ochre Bio Ltd.

[1] Ochre Bio Ltd.. (6/16/21). "Press Release: Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures". Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]